2 weeks 2 Biotech Stocks You Can Buy Hand Over Fist This MonthThe Motley Fool Both stocks have made significant breakthroughs. Biotech · Biotech Stocks X
2 days Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?The Motley Fool X
2 days Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Why Is BridgeBio Pharma, Inc. (BBIO) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Why Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
2 days Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & MoreZacks X
4 days China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drugInvesting.com X
4 days Biotech: 3 Reasons The Recent Selloff Is A Buying Opportunity For XBI (Upgrade)Seeking Alpha X
5 days The Zacks Analyst Blog Highlights SPDR S&P Biotech ETF, SPDR S&P Semiconductor ETF, First Trust Indxx Aerospace & Defense ETF, First Trust NASDAQ-100-Technology Sector Index Fund and iShares U.S. Digital Infrastructure and Real Estate ETFZacks X
5 days Here are 4 biotech stocks that could get a boost from Trump’s new regulatory climateMarketWatch X
1 week Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataZacks X
1 week Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a MonthThe Motley Fool X
2 weeks This biotech’s stock could double if its treatment for major depressive disorder succeeds, says MizuhoMarketWatch X
2 weeks Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation OpportunityThe Motley Fool X